Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Newcomb RA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Amonoo HL; Department of Psychosocial Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Daskalakis E; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lam JA; Harvard Medical School, Boston, Massachusetts, USA.; Department of Psychiatry, Cambridge Health Alliance, Cambridge, Massachusetts, USA., Wolfe ED; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA., Guo M; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Onyeaka HK; Harvard Medical School, Boston, Massachusetts, USA.; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., Newcomb RA; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Barata A; Harvard Medical School, Boston, Massachusetts, USA.; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., Ghanime PM; Harvard Medical School, Boston, Massachusetts, USA.; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., Keane EP; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA., Boardman AC; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA., Cutler C; Harvard Medical School, Boston, Massachusetts, USA.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Pirl WF; Department of Psychosocial Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Peteet JR; Department of Psychosocial Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Gudenkauf LM; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA., Lee SJ; Division of Medical Oncology, Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington, USA., Huffman JC; Harvard Medical School, Boston, Massachusetts, USA.; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., El-Jawahri A; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Publikováno v:
Journal of psychosocial oncology [J Psychosoc Oncol] 2024 Oct 07, pp. 1-16. Date of Electronic Publication: 2024 Oct 07.
Autor:
DeFilipp Z; Massachusetts General Hospital, Boston, Massachusetts, United States., Kim HT; Dana-Farber Cancer Inst., Boston, Massachusetts, United States., Cheng GS; Fred Hutch Cancer Center, Seattle, Washington, United States., Hamilton BK; Cleveland Clinic, Cleveland, Ohio, United States., Chhabra S; Medical College of Wisconsin, United States., Hamadani M; Medical College of Wisconsin, Wauwatosa, Wisconsin, United States., Sandhu KS; City of Hope Medical Center, Duarte, California, United States., Perez LE; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States., Lee C; Huntsman Cancer Institute, University of Utah, United States., Brennan TL; Massachusetts General Hospital, Boston, Massachusetts, United States., Garrelts C; Massachusetts General Hospital, Boston, Massachusetts, United States., Brown BM; Massachusetts General Hospital, Boston, Massachusetts, United States., Gallagher KME; Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, United States., Newcomb RA; Massachusetts General Hospital, Boston, Massachusetts, United States., El-Jawahri A; Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, United States., Chen YB; Massachusetts General Hospital, Boston, Massachusetts, United States.
Publikováno v:
Blood advances [Blood Adv] 2024 Oct 04. Date of Electronic Publication: 2024 Oct 04.
Autor:
Newcomb RA; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: richard.newcomb@mgh.harvard.edu., Gao L; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Vanderklish J; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Tse A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Saylor M; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Danielson C; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Wali N; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Frigault M; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., McAfee S; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Spitzer T; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., DeFilipp Z; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Chen YB; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Amonoo HL; Harvard Medical School, Boston, Massachusetts; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts., El-Jawahri A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jul; Vol. 30 (7), pp. 700-711. Date of Electronic Publication: 2024 Apr 27.
Autor:
DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Damania AV; Platform for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Kim HT; Department of Data Science, Dana-Farber Cancer Institute and Harvard T. H. Chan School of Public Health, Boston, MA., Chang CC; Platform for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., El-Jawahri A; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., McAfee SL; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Bottoms AS; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Toncheva V; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Smith MM; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Dolaher M; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Perry L; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., White M; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Diana B; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Connolly S; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Dey BR; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Frigault MJ; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Newcomb RA; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., O'Donnell PV; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Spitzer TR; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Mansour MK; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA., Weber D; Departments of Hematology and Oncology, Internal Medicine III, University of Regensburg, Regensburg, Germany., Ajami NJ; Platform for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Hohmann E; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA., Jenq RR; Platform for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Chen YB; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2024 May 14; Vol. 8 (9), pp. 2074-2084.
Autor:
Newcomb RA; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Johnson PC; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Yang D; Duke University School of Medicine, Durham, NC, USA., Holmbeck K; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Choe J; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Nabily A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Lark P; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Dhawale T; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Amonoo HL; Harvard Medical School, Boston, MA, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA., El-Jawahri A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
The oncologist [Oncologist] 2024 May 03; Vol. 29 (5), pp. 441-449.
Autor:
Barata A; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: abarata@mgh.harvard.edu., Dhawale T; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts., Newcomb RA; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts., Amonoo HL; Harvard Medical School, Boston, Massachusetts; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts., Nelson AM; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Yang D; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Karpinski K; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Holmbeck K; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Farnam E; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Frigault M; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts., Johnson PC; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts., El-Jawahri A; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Apr; Vol. 30 (4), pp. 452.e1-452.e11. Date of Electronic Publication: 2024 Jan 17.
Autor:
Johnson PC; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Dhawale T; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Newcomb RA; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Barata A; Harvard Medical School, Boston, MA.; Department of Psychiatry, Massachusetts General Hospital, Boston, MA., Karpinski K; Department of Psychiatry, Massachusetts General Hospital, Boston, MA., Lavoie MW; UMass Chan Medical School, Worchester, MA., Vaughn D; University of Tennessee Health Science Center College of Medicine, Memphis, TN., Hennessey K; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Schneider D; Department of Psychiatry, Massachusetts General Hospital, Boston, MA., Amonoo HL; Harvard Medical School, Boston, MA.; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA., Volandes A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., El-Jawahri A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Feb 27; Vol. 22 (2). Date of Electronic Publication: 2024 Feb 27.
Autor:
Amonoo HL; Department of Psychosocial Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Daskalakis E; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA., Deary EC; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA., Guo M; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Boardman AC; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA., Keane EP; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lam JA; Harvard Medical School, Boston, Massachusetts, USA.; Department of Psychiatry, Cambridge Health Alliance, Cambridge, Massachusetts, USA., Newcomb RA; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Gudenkauf LM; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA., Brown LA; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.; La Trobe University, Melbourne, Victoria, Australia., Onyeaka HK; Harvard Medical School, Boston, Massachusetts, USA.; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., Lee SJ; Division of Medical Oncology, Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington, USA., Huffman JC; Harvard Medical School, Boston, Massachusetts, USA.; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., El-Jawahri A; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Publikováno v:
Psycho-oncology [Psychooncology] 2024 Feb; Vol. 33 (2), pp. e6307.
Autor:
Nelson AM; 1Massachusetts General Hospital, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts., Yang D; 1Massachusetts General Hospital, Boston, Massachusetts., Jagielo AD; 1Massachusetts General Hospital, Boston, Massachusetts., D'Alotto J; 1Massachusetts General Hospital, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts., Poliquin C; 1Massachusetts General Hospital, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts., Rabideau DJ; 1Massachusetts General Hospital, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts., Cronin KG; 1Massachusetts General Hospital, Boston, Massachusetts., Newcomb RA; 1Massachusetts General Hospital, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts., Chen YB; 1Massachusetts General Hospital, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts., DeFilipp Z; 1Massachusetts General Hospital, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts., Greer JA; 1Massachusetts General Hospital, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts., El-Jawahri A; 1Massachusetts General Hospital, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts., Traeger L; 1Massachusetts General Hospital, Boston, Massachusetts.; 3University of Miami, Coral Gables, Florida.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Feb; Vol. 22 (1), pp. 34-42.